Newson Clinic

Redefining menopause and hormone-health care through clinical excellence

Newson Clinics delivers personalised, evidence-based menopause and hormone-health care through both in-person and virtual appointments. Combining medical expertise, diagnostic capability, and a hybrid model of accessibility, the clinics provide world-leading care for women seeking tailored hormonal health support and long-term wellbeing.

About Newson Clinics

Newson Clinics provides comprehensive menopause and hormone-health services, offering personalised consultations, hormone therapy management, and diagnostic testing. Its care model integrates lifestyle advice, evidence-based treatment, and follow-up support, ensuring women receive continuity of care and measurable outcomes.
Through both physical sites and secure virtual consultations, Newson Clinics achieves national accessibility while maintaining a patient retention rate of approximately 70%.

Visit Newson Clinics

Growth Highlights

✔ Over 28,000 active patients 

✔ Virtual and in-person – National reach enabled by a hybrid model and satellite clinics

✔ Approximately patients have a 70% retention rate 

PEAL’s Role

PEAL supported the platform by:

  • Supporting the global roll-out of Newson Clinics through a scalable hybrid model of physical and virtual sites.
  • Strengthening leadership and data capabilities to better leverage clinical and operational insights.
  • Enhancing clinical systems and governance frameworks to ensure sustainable growth and world-class patient outcomes.

    PEAL’s Investment Thesis

    PEAL chose to invest in Newson Clinics to build on its position as one of the UK’s leading providers of evidence-based menopause and hormone-health care.

    The business operates a scalable hybrid model of in-person and virtual consultations, serving over 28,000 active patients with consistently high retention and satisfaction rates.

    With growing global demand for personalised hormone and longevity care, Newson Clinics offers a strong platform for international expansion and data-driven clinical excellence which fully aligned with PEAL’s strategy of supporting high-impact, technology-enabled healthcare businesses.